| Nov 11 |
What Makes XOMA Royalty (XOMA) a New Buy Stock
|
| Nov 10 |
XOMA Royalty Corporation (NASDAQ:XOMA) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates
|
| Nov 9 |
XOMA Royalty Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
| Nov 7 |
XOMA GAAP EPS of -$1.59, revenue of $7.2M
|
| Nov 7 |
XOMA Royalty (XOMA) Reports Q3 Loss, Tops Revenue Estimates
|
| Nov 7 |
XOMA Royalty: Q3 Earnings Snapshot
|
| Nov 7 |
XOMA Royalty Reports Third Quarter 2024 Financial Results and Highlights Recent Activities
|
| Oct 22 |
Twist Bioscience enters into purchase agreement with XOMA Royalty
|
| Oct 22 |
XOMA Royalty Significantly Expands its Royalty and Milestone Portfolio with the Addition of Over 60 Early-Stage Programs from Twist Bioscience
|
| Oct 21 |
Investors in XOMA Royalty (NASDAQ:XOMA) have seen favorable returns of 72% over the past year
|
